您当前所在位置:首页 > 材料科学 > 新品上市
序号 标题 次数 作者 发布时间
75781 Ald-Ph-amido-PEG2-C2-Pfp ester CAS:2101206-60-2 93 zyl 2024-12-19
75782 cas:1228105-52-9,DM4-SMCC, ADC试剂 102 kx 2024-12-19
75783 马来酰亚胺-八聚乙二醇-缬氨酸-瓜氨酸-PAB-PNP酯,ADC定制 93 wyh 2024-12-19
75784 cas:863971-56-6,Val-Cit-PAB-MMAF, ADC试剂 69 kx 2024-12-19
75785 SPDMB CAS:2101206-29-3合成方法 89 zyl 2024-12-19
75786 cas:2055041-39-7,Mal-PEG4-Val-Cit-PAB-OH,ADC定制 87 wyh 2024-12-19
75787 cas:1347750-81-5,Mal-NH-PEG2-CH2CH2COOPFP ester, ADC试剂 79 kx 2024-12-19
75788 金属螯合剂DOTA偶联α-MSH八肽类似物 66 h 2024-12-19
75789 cas:1286715-33-0,2,5-Dioxopyrrolidin-1-yl 4-methyl-4-((2-methyl-5-oxo-5-(2-(trimethylsilyl)ethoxy)pentan-2-yl)disulfanyl)pentanoate 104 kx 2024-12-19
75790 DOTA-conjugated multivalent cyclic-RGD DOTA-共轭多价环RGD肽树枝状大分子 75 h 2024-12-19
75791 Azidoethyl-SS-ethylazide CAS:352305-38-5 81 zyl 2024-12-19
75792 CAS: 870487-09-5, Boc-Val-Cit-PAB 80 WYQ 2024-12-19
75793 cas:2101206-67-9,Ald-Ph-amido-PEG1-C2-Pfp ester, ADC试剂 72 kx 2024-12-19
75794 Ald-Ph-amido-PEG11-NH-Boc CAS:1245813-70-0 103 zyl 2024-12-19
75795 HSA-2-iminothiolane-DOTA HSA-2-亚氨基硫醇-DOTA 92 h 2024-12-19
75796 cas:1222787-24-7,2,5-Dioxopyrrolidin-1-yl 4-((2-((2-(2-(4-(2,6-dioxo-1,3-dipropyl-2,3,6,9-tetrahydro-1H-purin-8-yl)phenoxy)acetamido)ethyl)amino)ethyl)disulfanyl)-4-oxobutanoate 204 kx 2024-12-19
75797 Tr-PEG5-OH CAS:141282-24-8物理化学性质 97 zyl 2024-12-19
75798 CAS: 870487-08-4,Boc-Val-Cit,(S)-2-((S)-2-((叔丁氧基羰基)氨基)-3-甲基丁酰胺基)-5-脲基戊酸 97 WYQ 2024-12-19
75799 DOTA-8-Aoc-BBN[7-14]NH 109 h 2024-12-19
75800 Fmoc-PEG3-Val-Cit,N-Fluorenylmethoxycarbonyl-triethylene glycol-Val-Cit 85 WYQ 2024-12-19
75801 CAS: 2226472-28-0,DBCO-PEG4-Val-Cit-PAB-PNP 79 WYQ 2024-12-19
75802 CAS: 2055024-64-9,Azido-PEG4-Val-Cit-PAB-OH 85 WYQ 2024-12-19
75803 CAS: 870487-09-5,Boc-Val-Cit-PAB 86 WYQ 2024-12-19
75804 CAS:784105-33-5 Amino-PEG3-C2-acid的介绍 75 zyl 2024-12-19
75805 CAS 863971-53-3:Fmoc-Val-Cit-PAB-PNP 89 WYQ 2024-12-19
75806 Ald-Ph-amido-PEG11-C2-NH2 CAS:1337889-01-6 72 zyl 2024-12-19
75807 cas:2003260-13-5 , MA-PEG4-Ala-Ala-PAB-PNP,ADC定制 75 wyh 2024-12-19
75808 DOTA-NCS-6-Ahx-Phe 19-ST[1-19] DOTA偶联ST肽类似物 104 h 2024-12-19
75809 1,4,7,10-四氮杂-n-(1-羧基-3-(4-硝基苯基)丙基)-n,N , N ‴-tris(acetic酸)环十二烷(PA-DOTA) 70 h 2024-12-19
75810 CAS 159858-22-7:Fmoc-Val-Cit-PAB-OH 64 WYQ 2024-12-19
75811 cas:5117-19-1,Octanethyl glycol ,八乙二醇的主要特点 101 zyl 2024-12-19
75812 CAS 159857-79-1:Val-Cit-PAB-OH,缬氨酸(Val)、琥珀酰亚胺(Cit)和对氨基苯甲酸(PAB)的衍生物 112 WYQ 2024-12-19
75813 SPDP-Val-Cit-PAB-OH,ADC定制 70 wyh 2024-12-19
75814 DOTA-LVT 螯合剂DOTA偶联Lys8-血管收缩素 104 h 2024-12-19
75815 cas:2054345-67-2,azido-tris(ethylenoxy)-L-alanine TFA Salt化学性质 84 zyl 2024-12-19
75816 cas:68617-64-1,SPDP acid,3-(2-吡啶二硫代)丙酸的合成方法 121 zyl 2024-12-19
75817 1,4,7,10-四(羧甲基)-1,4,7,10-四氮杂环十二烷单酰胺偶联葡萄糖 87 h 2024-12-19
75818 PEG-P(Asp-Gd-DOTA)Gd‐DOTA偶联聚乙二醇改性聚天冬氨酸 92 h 2024-12-19
75819 cas:70539-42-3,EGS Crosslinker,乙二醇-双(琥珀酸N-羟基琥珀酰亚胺酯)的结构式 145 zyl 2024-12-19
75820 CXCR4导向的五肽[(68)Ga]喷替沙福(环(-D-Tyr-N-Me-D-Orn(AMB-DOTA)-L-Arg-L-2-Nal-Gly-)) 128 h 2024-12-19
75821 α-hexadecyl-DOTA α-十六烷基-DOTA 86 h 2024-12-19
75822 Methyltetrazine-SS-NHS 甲基四唑-双硫键-活性酯的合成方法 77 zyl 2024-12-19
75823 DOTA-AgRP-6E 115 h 2024-12-19
75824 DOTA-morab-003 DOTA偶联单克隆抗体MORAb-003 79 h 2024-12-19
75825 DOTA-Bz-folate DOTA-Bz-叶酸 95 h 2024-12-19
库存查询